发明名称 Small molecule inhibitors of rotamase enzyme activity and their use in the treatment of neurological disorders
摘要 The disclosed relates to neurotrophic N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity. Described is a non-immunosupressive compound of formula (I), wherein: R1 is selected from the group consisting of an optionally substituted C1-C9 straight or branched chain alkyl or alkenyl group, C3 or C5 cycloalkyl, C5-C7 cycloalkenyl, where the alkyl, alkenyl, cycloalkyl, or cycloalkenyl groups may optionally have one or more hydrogen atoms replaced with C1-C4 alkyl, C1-C4 alkenyl or hydroxy, or Ar1, wherein Ar1 is selected from 1-naphthyl, 2-napthyl, 2- indolyl, 3-indolyl, 2-furyl, 3-furyl, 2-thiazolyl, 2- thienyl, 3-thienyl, 2-, 3-, or 4-pyridyl, and phenyl, having one to three substituents which are independently selected from hydrogen, halo, hydroxyl, nitro, trifluoromethyl, C1-C6 straight or branched alkyl or alkenyl, C1-C4 alkoxy or C1-C4 alkenyloxy, phenoxy, benzyloxy, and amino; X is oxygen, sulphur, methylene, or (CH2), or H2; Y is oxygen or NR2, wherein R2 is hydrogen or C1-C6 alkyl; and Z is C2-C6 straight or branched chain alkyl or alkenyl, wherein the alkyl or alkenyl chain is substituted in one or more positions with Ar1 as defined above, or C3-C8 cycloalkyl; cycloalkyl connected by a C1-C6 straight or branched alkyl or alkenyl chain, or Ar2 where Ar2 is selected from 2-indolyl, 3-indolyl, 2-furyl, 3-furyl, 2- thiazolyl, 2-thienyl, 3-thienyl, 2-, 3-, or 4-pyridyl, and phenyl, having one to three substituents which are independently selected from hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, C1-C6 straight or branched alkyl or alkenyl, C1-C4 alkoxy or C1-C4 alkenyloxy, phenoxy, benzyloxy, and amino.
申请公布号 NZ510086(A) 申请公布日期 2003.03.28
申请号 NZ19960510086 申请日期 1996.06.05
申请人 GUILFORD PHARMACEUTICALS INC 发明人 HAMILTON, GREGORY S;STEINER, JOSEPH P
分类号 C12N9/99;A61K31/00;A61K31/40;A61K31/401;A61K31/4025;A61K31/405;A61K31/427;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/444;A61K31/454;A61K38/00;A61K45/00;A61P21/00;A61P21/02;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/24;A61P25/28;A61P37/00;A61P43/00;C07B53/00;C07D207/16;C07D401/04;C07D401/06;C07D405/06;C07D405/10;C07D405/12;C07D407/04;C07D409/04;C07D409/06;C07D409/12;C07D409/14;C07D417/02;C07D417/04;C07D417/12;C07K5/078;(IPC1-7):A61K31/40 主分类号 C12N9/99
代理机构 代理人
主权项
地址